Description

Endjerix-V (HBsAg) for adults 1 ml. 20 mcg. №10 vial

Ingredients

Active ingredient: HBsAg (Hepatitis B surface antigen) 20 mcg per 1 ml.

Dosage

Recommended dosage: 1 ml injection for adults. Consult a healthcare professional for personalized dosing instructions.

Indications

Indicated for: Prevention of Hepatitis B virus infection in adults.

Contraindications

Do not use if:

• Known hypersensitivity to any component of the vaccine
• History of severe allergic reaction to a previous dose

Directions

Administration: Administer intramuscularly. Shake well before use. Follow healthcare provider’s instructions.

Scientific Evidence

Endjerix-V (HBsAg) has been extensively studied for its efficacy in preventing Hepatitis B infection. Clinical trials have shown high rates of seroprotection after vaccination, indicating a robust immune response against the virus.

Research published in the Journal of Infectious Diseases demonstrated the long-term effectiveness of HBsAg vaccines in reducing the incidence of Hepatitis B infection, especially in high-risk populations such as healthcare workers and individuals with chronic liver disease.

Additional Information

It is essential to complete the full vaccination schedule as recommended by healthcare professionals to ensure adequate protection against Hepatitis B. In case of any adverse reactions or concerns, seek medical advice promptly.

Consult your healthcare provider to understand the benefits of Endjerix-V compared to other Hepatitis B vaccines available in the market. Individual response to vaccines may vary, and personalized medical advice is crucial for optimal protection.